Lung Cancer Staging
The Pentax EB-1970UK is the cornerstone tool for lung cancer staging via EBUS-TBNA across hospital thoracic oncology services and dedicated lung cancer staging programmes. Real-time ultrasound-guided needle sampling of paratracheal, mediastinal, and hilar lymph nodes supports accurate N-stage determination, treatment planning, and confident clinical decision-making across multidisciplinary lung cancer programmes and thoracic surgical referral services worldwide today.
Mediastinal Lymphadenopathy Diagnosis
Mediastinal lymphadenopathy diagnosis benefits substantially from the EB-1970UK's curved linear-array transducer and real-time EBUS-TBNA capability. Suspected sarcoidosis, lymphoma, tuberculosis, and other mediastinal pathologies can be sampled for cytology and tissue diagnosis under continuous ultrasound guidance across hospital pulmonology, thoracic medicine, and lymphadenopathy diagnostic services worldwide today.
Non-Infiltrating Tumour Evaluation
Evaluation of non-infiltrating tumours on the outer bronchial wall benefits substantially from the EB-1970UK's sonographic visualisation beyond conventional bronchoscopy. Tumour size, shape, location, and relationship to surrounding mediastinal structures inform staging decisions and treatment planning across thoracic oncology and surgical services worldwide today during routine practice.
EBUS-Guided Transbronchial Needle Aspiration
EBUS-guided TBNA is the primary clinical application of the EB-1970UK, supporting targeted needle sampling of suspicious lymph nodes and lesions under continuous ultrasound guidance. EBUS-TBNA delivers reliable cytology and tissue specimens for diagnostic evaluation across hospital interventional pulmonology, dedicated bronchoscopy suites, and thoracic oncology services worldwide today during daily lung cancer staging case workflows.
Elastography-Assisted Lymph Node Assessment
Elastography-assisted lymph node assessment benefits from the EB-1970UK's high-quality ultrasound platform supporting strain ratio measurement for differentiating malignant from benign lymph nodes. Elastography supports targeted biopsy decisions and improved diagnostic confidence across lung cancer staging, mediastinal evaluation, and lymphadenopathy diagnostic services in tertiary thoracic oncology centres worldwide today.
